After Bribery Settlement, Eli Lilly Sees Shareholder Derivative Suit
Currently dealing with allegations in China, the company's board is being sued for its handling of a bribery matter it settled last year with the SEC.
To read more
Subscribe to Global Investigations Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Investigations Review experts.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10